Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

DR 8 DME 10 Ų I. APX3330 Program Update INDIANA UNIVERSITY MELVIN AND BREN SIMON CANCER CENTER Mark Kelley, PhD Founder Apexian/APX3330 Cleveland Clinic Cole Eye Institute Peter Kaiser, MD Harvard Medical School Ocuphire PHARMA Retina-Vitreous Associates Medical Group David Boyer, MD Chicago Medical School
View entire presentation